AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

BETAMETHASONE / NEOMYCINE

15 registrations across 3 African markets— 9 active

Markets with BETAMETHASONE / NEOMYCINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
DIMETASONE NEOMYCINE
Pommade dermique
🇹🇳TunisiaPHARMADERMexpiredJul 2013
VALECORT NEOMYCINE
Lotion
🇹🇳TunisiaPHARMADERMexpiredJun 1997
VALECORT NEOMYCINE
Pommade dermique
🇹🇳TunisiaPHARMADERMexpiredNov 1996
VALECORT NEOMYCINE
Creme dermique
🇹🇳TunisiaPHARMADERMexpiredNov 1996
DERMOSONE NEO
Pommade dermique
🇹🇳TunisiaOPALIA PHARMAexpiredJan 1993
DERMOSONE NEO
Creme dermique
🇹🇳TunisiaOPALIA PHARMAexpiredJan 1993
DIPROSONE NEO
CREME
🇲🇦Moroccoactive
SKINOSONE NEOMYCINE
POMMADE
🇲🇦Moroccoactive
BETNEVAL NEOMYCINE
POMMADE
🇲🇦Moroccoactive
DIPROSONE NEO
POMMADE
🇲🇦Moroccoactive
BETNEVAL NEOMYCINE
CREME
🇲🇦Moroccoactive
BETNEVAL NEOMYCINE
pommade dermique / 1 % / 3 %
🇸🇳SenegalGLAXOactive
CELESTODERM NEOMYCINE
pommade dermique / 10 mg / 30 mg
🇸🇳SenegalUNICETactive
CELESTODERM NEOMYCINE
crème dermique / 10 mg / 35 mg
🇸🇳SenegalUNICETactive
SKINOSONE NEOMYCINE
CREME
🇲🇦Moroccoactive

BETAMETHASONE / NEOMYCINE in Africa — Regulatory Overview

BETAMETHASONE / NEOMYCINE is registered across 3 African markets with 15 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Tunisia, Senegal. AfricaRegulatory refreshes this data daily from official government sources.

Of the 15 registrations, 9 (60%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.